HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
H3-3B
H3.3 histone B
Chromosome 17 Β· 17q25.1
NCBI Gene: 3021Ensembl: ENSG00000132475.11HGNC: HGNC:4764UniProt: B2R4P9
129PubMed Papers
20Diseases
0Drugs
20Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
DATA QUALITY
βœ“ Swiss-Prot Reviewed
Bryant-Li-Bhoj neurodevelopmental syndrome 1gliomaBryant-Li-Bhoj neurodevelopmental syndrome 2malignant glioma
✦AI Summary

H3F3B encodes H3.3B, a replacement histone variant that differs from replication-dependent histones by being expressed throughout the cell cycle rather than only during DNA replication 1. The gene is located on chromosome 17 as a solitary gene, contrasting with clustered replication-dependent histone genes 1. H3.3B contains characteristic structural features including introns in both the 5' untranslated region and coding sequence, plus polyadenylation signals rather than histone-specific dyad symmetry elements 1. Transcriptionally, H3F3B is regulated by Oct-1, CREB/ATF, and AP-1 transcription factors binding to its proximal promoter 2. The gene shows tissue-specific expression patterns, being primarily expressed in adult tissues while replication-dependent H3.1 is mainly expressed in fetal tissues 3. Clinically, germline variants in H3F3B cause Bryant-Li-Bhoj syndrome, a neurodevelopmental disorder characterized by intellectual disability, craniofacial anomalies, and abnormal neuroimaging 4. Additionally, somatic H3F3B mutations, particularly K36M substitutions, are associated with malignant chondroblastoma, a rare bone tumor with high rates of recurrence and metastasis 5. The gene is also overexpressed in colorectal cancer, suggesting potential utility as a prognostic biomarker 6.

Sources cited
1
H3F3B gene structure, chromosome location, and distinction from replication-dependent histones
PMID: 8586426
2
Transcriptional regulation by Oct-1, CREB/ATF, and AP-1 factors
PMID: 9188772
3
Tissue-specific expression patterns with adult tissue predominance
PMID: 12909349
4
Germline variants cause Bryant-Li-Bhoj neurodevelopmental syndrome
PMID: 38678163
5
K36M mutations in malignant chondroblastoma
PMID: 40348060
6
Overexpression in colorectal cancer as potential biomarker
PMID: 28280610
Disease Associationsβ“˜20
Bryant-Li-Bhoj neurodevelopmental syndrome 1Open Targets
0.74Strong
gliomaOpen Targets
0.66Moderate
Bryant-Li-Bhoj neurodevelopmental syndrome 2Open Targets
0.62Moderate
malignant gliomaOpen Targets
0.46Moderate
breast carcinomaOpen Targets
0.44Moderate
pilocytic astrocytomaOpen Targets
0.41Moderate
genetic disorderOpen Targets
0.39Weak
Global developmental delayOpen Targets
0.39Weak
Intellectual disabilityOpen Targets
0.39Weak
Brain imaging abnormalityOpen Targets
0.39Weak
Delayed speech and language developmentOpen Targets
0.39Weak
Short statureOpen Targets
0.39Weak
cancerOpen Targets
0.38Weak
bone giant cell tumorOpen Targets
0.37Weak
astrocytomaOpen Targets
0.37Weak
Spinal Cord AstrocytomaOpen Targets
0.37Weak
Bryant-Li-Bhoj neurodevelopmental syndromeOpen Targets
0.37Weak
anaplastic astrocytomaOpen Targets
0.37Weak
gangliogliomaOpen Targets
0.37Weak
Malignancy in Giant Cell Tumor of BoneOpen Targets
0.37Weak
Pathogenic Variants20
NM_005324.5(H3-3B):c.365C>T (p.Pro122Leu)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 122
NM_005324.5(H3-3B):c.377A>G (p.Gln126Arg)Pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2|H3-3B-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 126
NM_005324.5(H3-3B):c.52C>T (p.Arg18Cys)Pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜…β˜†β˜†2025β†’ Residue 18
NM_005324.5(H3-3B):c.103G>A (p.Gly35Arg)Pathogenic
not provided|Neurodevelopmental disorder
β˜…β˜…β˜†β˜†2022β†’ Residue 35
NM_005324.5(H3-3B):c.29A>G (p.Lys10Arg)Pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2025β†’ Residue 10
NM_005324.5(H3-3B):c.68C>T (p.Thr23Met)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 23
NM_005324.5(H3-3B):c.11C>T (p.Thr4Ile)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2024β†’ Residue 4
NM_005324.5(H3-3B):c.91C>T (p.Pro31Ser)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2024β†’ Residue 31
NM_005324.5(H3-3B):c.376C>A (p.Gln126Lys)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2023β†’ Residue 126
NM_005324.5(H3-3B):c.98C>T (p.Thr33Ile)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 33
NM_005324.5(H3-3B):c.68C>G (p.Thr23Arg)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2023β†’ Residue 23
NM_005324.5(H3-3B):c.35C>T (p.Thr12Ile)Likely pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜…β˜†β˜†β˜†2022β†’ Residue 12
NM_005324.5(H3-3B):c.31T>C (p.Ser11Pro)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 11
NM_005324.5(H3-3B):c.37G>A (p.Gly13Ser)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2021β†’ Residue 13
NM_005324.5(H3-3B):c.88G>C (p.Ala30Pro)Pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜†β˜†β˜†β˜†2022β†’ Residue 30
NM_005324.5(H3-3B):c.155T>A (p.Ile52Asn)Pathogenic
Global developmental delay;Short stature;Delayed speech and language development;Intellectual disability;Brain imaging abnormality|Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜†β˜†β˜†β˜†2022β†’ Residue 52
NM_005324.5(H3-3B):c.365C>G (p.Pro122Arg)Pathogenic
Bryant-Li-Bhoj neurodevelopmental syndrome 2
β˜†β˜†β˜†β˜†2022β†’ Residue 122
NM_005324.5(H3-3B):c.410_411del (p.Ter137CysextTer?)Likely pathogenic
Global developmental delay;Short stature;Delayed speech and language development;Intellectual disability;Brain imaging abnormality
β˜†β˜†β˜†β˜†2021β†’ Residue 137
NM_005324.5(H3-3B):c.28A>G (p.Lys10Glu)Likely pathogenic
Global developmental delay;Short stature;Delayed speech and language development;Intellectual disability;Brain imaging abnormality
β˜†β˜†β˜†β˜†2021β†’ Residue 10
NM_005324.5(H3-3B):c.68C>A (p.Thr23Lys)Likely pathogenic
Global developmental delay;Short stature;Delayed speech and language development;Intellectual disability;Brain imaging abnormality
β˜†β˜†β˜†β˜†2021β†’ Residue 23
View on ClinVar β†—
Related Genes
ATRXProtein interaction100%BRDTProtein interaction100%CENPAProtein interaction100%CHD3Protein interaction100%CHD4Protein interaction100%DAXXProtein interaction100%
Tissue Expression6 tissues
Brain
100%
Lung
37%
Bone Marrow
26%
Ovary
26%
Liver
22%
Heart
8%
Gene Interaction Network
Click a node to explore
H3-3BATRXBRDTCENPACHD3CHD4DAXX
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt P84243
View on AlphaFold β†—
RankingsWhere H3-3B stands among ~20K protein-coding genes
  • #3,622of 20,598
    Most Researched129 Β· top quartile
  • #2,186of 5,498
    Most Pathogenic Variants20
Genes detectedH3-3B
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The human replacement histone H3.3B gene (H3F3B).
PMID: 8586426
Genomics Β· 1995
1.00
2
Investigation of the human
PMID: 28280610
J Gastrointest Oncol Β· 2017
0.90
3
Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals.
PMID: 38678163
Eur J Hum Genet Β· 2024
0.80
4
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally Mature.
PMID: 40348060
Mod Pathol Β· 2025
0.70
5
Transcriptional regulation of the human replacement histone gene H3.3B.
PMID: 9188772
FEBS Lett Β· 1997
0.60